American Medical Association
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1847-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.ama-assn.org/
Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Understanding Physician Work Motivation
- Conditions
- Physician Work Motivation
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- American Medical Association
- Target Recruit Count
- 4500
- Registration Number
- NCT02263521
Improving Health Outcomes: Blood Pressure
- Conditions
- Hypertension
- First Posted Date
- 2013-12-27
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- American Medical Association
- Target Recruit Count
- 10
- Registration Number
- NCT02021981
- Locations
- 🇺🇸
American Medical Association, Chicago, Illinois, United States
Evaluating Effectiveness of Educational Intervention to Help Physicians Address Inappropriate Patient Requests for Direct-to-Consumer Advertised Prescription Medications
- Conditions
- Lumbosacral Muscle Strain
- First Posted Date
- 2009-06-08
- Last Posted Date
- 2009-06-08
- Lead Sponsor
- American Medical Association
- Target Recruit Count
- 133
- Registration Number
- NCT00915291
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸Creighton University School of Medicine, Omaha, Nebraska, United States
🇺🇸University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
News
PolarityBio Secures AMA CPT Codes for Autologous Skin Construct Therapy, Advancing Wound Healing Treatment Access
The American Medical Association CPT Editorial Panel has accepted PolarityBio's Category III CPT Code Application for its autologous heterogeneous skin construct graft therapy.
FDA Approves Second Generic Mifepristone Despite Trump Administration Safety Review
The FDA approved a new generic version of mifepristone manufactured by Evita Solutions LLC, marking the second generic approval for the abortion medication.
Major Medical Organizations Excluded from CDC Vaccine Advisory Workgroups
Leading medical organizations including the American Medical Association, American Academy of Pediatrics, and Infectious Diseases Society of America have been barred from CDC vaccine advisory workgroups.
OpenEvidence Raises $210 Million Series B to Expand AI-Powered Medical Research Platform for Physicians
OpenEvidence, an AI-powered medical search engine for physicians, raised $210 million in Series B funding at a $3.5 billion valuation, co-led by Google Ventures and Kleiner Perkins.
IMVARIA Presents Real-World Data on FDA-Authorized AI Diagnostic Service for Pulmonary Fibrosis at ATS 2025
IMVARIA's Fibresolve, the first FDA-authorized AI adjunctive diagnostic service for lung fibrosis, demonstrates real-world clinical utility in multi-site experiences presented at ATS 2025 Conference.
Trump Administration Suspends Enforcement of Mental Health Parity Rule, Raising Concerns Over Treatment Access
The Trump administration has suspended enforcement of updated Mental Health Parity and Addiction Equity Act regulations that were finalized in September 2024 under the Biden administration.
U.S. Surgeon General Pushes for Enhanced Cancer Warning Labels on Alcohol Products
U.S. Surgeon General Vivek Murthy releases a comprehensive report linking alcohol to 100,000 cancer cases and 20,000 cancer deaths annually in the United States.
AMA Debates Physician Compensation for Prior Authorization Work at Interim Meeting
The American Medical Association's House of Delegates discussed a resolution to establish legislation requiring fair reimbursement for time spent on prior authorization processes across Medicare Advantage, Medicaid, and commercial plans.
UnitedHealthcare Launches Nationwide 'Gold Card' Program to Streamline Prior Authorization Process
UnitedHealthcare announces implementation of a national Gold Card program starting October 1st, aiming to reduce prior authorization burden for qualifying healthcare providers with high approval rates.